Carroll M Leevy
Affiliation: New Jersey
- Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathyCarroll B Leevy
The New Jersey Medical Liver Center, 90 Bergen Street, Suite 2100, Newark, NJ 07103, USA
Dig Dis Sci 52:737-41. 2007..001). Treatment of hepatic encephalopathy with rifaximin was associated with lower hospitalization frequency and duration, lower hospital charges, better clinical status, and fewer adverse events...
- Immunology of alcoholic liver diseaseCarroll B Leevy
University of Medicine and Dentistry of New Jersey Newark, New Jersey Medical School, Liver Center, Sammy Davis Jr National Liver Institute, 150 Bergen Street, P O Box 1709, Newark, NJ 07101 1709, USA
Clin Liver Dis 9:55-66. 2005..At present, research is underway to find modalities to correct the induced immunologic changes, so at this time, it is necessary to avoid alcoholism, with the use of social and educational programs to stop alcoholism...
- Nutritional aspects of alcoholic liver diseaseCarroll M Leevy
University of Medicine and Dentistry of New Jersey, 150 Bergen Street, Room H 245, Newark, NJ 07101 1709, USA
Clin Liver Dis 9:67-81. 2005..This is best achieved by using educational and social programs to convince patients and their caretakers of the great necessity to eliminate alcohol intake...
- Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to pegylated interferon alfa-2b and ribavirinCarroll B Leevy
Department of Medicine, Division of Gastroenterology Hepatology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School Liver Center, 185 South Orange Ave, Newark, NJ 07103, USA
Dig Dis Sci 53:1961-6. 2008..Daily consensus interferon therapy was safe and well tolerated in all patients. No dose reductions were required, and no patient discontinued therapy. Further studies of consensus interferon and ribavirin in nonresponders are warranted...